Active Ingredient History
Doconexent (Docosahexaenoic acid, DHA) is an omega-3 fatty acid that is a primary structural component of the human brain, cerebral cortex, skin, and retina. DHA is widely used as a food supplement, and is beleived to support healthy brain development in young childred, prevent cardiovascular disease and cognitive decline during Alzheimer's disease. Most of these claims, however, were not supported by clinical trials. DHA spray is used as a tanner. NCATS
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Asthenozoospermia (Phase 2/Phase 3)
Attention (Phase 3)
Brain Diseases (Phase 3)
Coronary Disease (Phase 3)
Cystic Fibrosis (Phase 2)
Depressive Disorder, Major (Phase 3)
Fatty Liver (Phase 1/Phase 2)
Healthy Volunteers (Phase 3)
Liver Cirrhosis (Phase 1/Phase 2)
Macular Degeneration (Phase 3)
Metabolic Syndrome (Phase 1/Phase 2)
Myocardial Infarction (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 1/Phase 2)
Obesity (Phase 1/Phase 2)
Organ Dysfunction Scores (Phase 2)
Oxidative Stress (Phase 2/Phase 3)
Pregnancy (Phase 3)
Psoriasis (Phase 1)
Retinopathy of Prematurity (Phase 2)
Sepsis (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue